New Zika Virus Test Authorized: Boosting South Carolina's Preparedness

Why it matters locally: The FDA's emergency authorization of a new Zika virus diagnostic test has direct implications for South Carolina residents, particularly pregnant women and those planning to conceive. While Zika outbreaks haven't been widespread within the state recently, the potential for the virus to return via travel or mosquito vectors remains a concern, especially given South Carolina's warm climate which is conducive to mosquito populations. This new test will allow for quicker and more accurate detection, enabling healthcare providers to offer faster diagnoses and counseling to affected individuals and couples. This could lead to improved prenatal care and public health responses if Zika cases were to resurface.

---

Washington D.C. – The Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test designed to detect the Zika virus. The test was developed by the Centers for Disease Control and Prevention (CDC). The authorization, announced [Date unavailable from source text], is intended to expand the nation's laboratory capacity for Zika testing. This action allows authorized laboratories within the United States to utilize the new CDC-developed test. The CDC developed the test and is expected to oversee its distribution to qualified laboratories. Further details regarding the rollout and specific capabilities of the test were not immediately available.